Reimea

Evidence / reviewed 18 October 2026

Know what the evidence actually supports.

A public summary of the supplied v23.1 design and security review. Source implementation, a successful deployment and independent assurance are different kinds of evidence.

Download evidence summary

The review baseline.

Source set: the supplied Meridian_v23.1.1_Design_Architecture_Reimea archive. Its platform and security documents identify Meridian v23.1.0 Helpdesk Plus as the reviewed runtime baseline.

Review type: documentation and source review. No live Azure environment was inspected. The supplied v23.1 verification record says targeted tests did not complete and Azure and live Graph were not tested.

What this is: a dated summary for an initial buyer discussion. It is not a certificate, independent assessment, uptime commitment or clinical approval.

Capabilities and their boundaries.

AreaSource-reviewed evidenceValidation still needed
DeploymentA separate Azure deployment per customer and environment is described.Verify the deployed resource configuration, identity permissions, network paths, recovery and operator responsibilities.
Identity and accessEntra and runtime role checks are present in the reviewed design.Validate route and object coverage, tenant binding, user assignment and session lifecycle. Do not infer default-deny coverage.
AI assistanceRegistered tasks use a shared gateway; Helpdesk suggestions require separate human actions.Review each task’s data, provider SKU and region, prompt handling and failure states. Source titles are not proof that every output claim is supported.
AuditApplication chains and structured log copies support review.The review records limits around failed storage writes, deletion detection and completeness. Independent checkpoints and protected retention need verification.
Encryption and retentionOptional record sealing and service encryption are described.Record sealing does not automatically cover Helpdesk/configuration, recordings, logs or backups. Retention is data-area specific; a setting is not evidence of an archive.
Clinical and patient modulesSynthetic demonstrators and target designs are present.Establish intended purpose, patient identity, connector approvals, safety/security evidence and deployment-owner approval before live use.

What a buyer can ask to see.

Current release evidence

Relevant workflow tests, route and permission tests, failure handling and a current dependency review for the proposed release.

Deployment evidence

Identity configuration, model regions, monitored failures, key handling, backup and restore results for the actual environment.

Independent and local assurance

Relevant security and accessibility assessments, safety evidence where applicable, and the named customer deployment approval.

No completed certification or independent penetration test is asserted on this page. Evidence must match the intended use and deployed release.

Request a briefing

Tell us what you want to improve. We aim to reply within two working days to arrange a suitable time.

Prefer email? [email protected]. A briefing request does not confirm an appointment.

Preview pilot scorecard · Download CSV